Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia

Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia

Abstract Background Decreased cerebral blood flow and systemic inflammation during heart failure (HF) increase the risk for vascular contributions to cognitive impairment and dementia (VCID) and Alzheimer disease-related dementias (ADRD). We previously demonstrated that PNA5, a novel glycosylated an...

Full description

Bibliographic Details
Main Authors:	Christina Hoyer-Kimura, John P. Konhilas, Heidi M. Mansour, Robin Polt, Kristian P. Doyle, Dean Billheimer, Meredith Hay
Format:	Article
Language:	English
Published:	BMC 2021-10-01
Series:	Journal of Neuroinflammation
Subjects:	Neurofilament light (NfL) Biomarker Vascular contributions to cognitive impairment and dementia Inflammation PNA5 Angiotensin-(1–7)
Online Access:	https://doi.org/10.1186/s12974-021-02281-1

Similar Items

Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia
by: Roberta Zanardini, et al.
Published: (2022-01-01)

Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia
by: Irene Frigerio, et al.
Published: (2023-01-01)

Serum NfL in Alzheimer Dementia: Results of the Prospective Dementia Registry Austria
by: Daniela Kern, et al.
Published: (2022-03-01)

Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
by: Jia-Hung Chen, et al.
Published: (2021-10-01)

Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases
by: Isabella Zanella, et al.
Published: (2022-05-01)

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
by: Marie Dreger, et al.
Published: (2021-04-01)

Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia
by: Guido Maria Giuffrè, et al.
Published: (2023-10-01)

Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer’s disease
by: Tandis Parvizi, et al.
Published: (2022-08-01)

Investigating Associations Between Inflammatory Biomarkers, Gray Matter, Neurofilament Light and Cognitive Performance in Healthy Older Adults
by: Hollis C. Karoly, et al.
Published: (2021-09-01)

Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release
by: David Encinas-Basurto, et al.
Published: (2022-03-01)

Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
by: Su-Hyun Kim, et al.
Published: (2022-08-01)

Corrigendum: Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
by: Su-Hyun Kim, et al.
Published: (2023-09-01)

Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders
by: Tobias Geis, et al.
Published: (2024-03-01)

Neurofilament Expression as a Biomarker of Post-COVID-19 Sudden Sensorineural Hearing Loss
by: Federica Zoccali, et al.
Published: (2023-06-01)

CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression
by: Qionghua Sun, et al.
Published: (2020-08-01)

Extracellular Vesicle Proteins and MicroRNAs Are Linked to Chronic Post-Traumatic Stress Disorder Symptoms in Service Members and Veterans With Mild Traumatic Brain Injury
by: Vivian A. Guedes, et al.
Published: (2021-10-01)

Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates
by: Chiara Gallingani, et al.
Published: (2024-03-01)

Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest
by: Helena Levin, et al.
Published: (2023-02-01)

The evaluation of serum brain‐derived neurotrophic factor and neurofilament light chain levels in patients with obstructive sleep apnea syndrome
by: Burak Arslan, et al.
Published: (2021-12-01)

Preliminary study of neurofilament light chain as a biomarker for hypoxia-induced neuronal injury in dogs
by: Taesik Yun, et al.
Published: (2023-10-01)

Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis
by: Alice Mariottini, et al.
Published: (2022-02-01)

CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study
by: Mette Scheller Nissen, et al.
Published: (2021-12-01)

Diffuse axonal injury in brain trauma: insights from alterations in neurofilaments
by: Declan Guenter Siedler, et al.
Published: (2014-12-01)

CSF and Serum Biomarkers of Cerebral Damage in Autoimmune Epilepsy
by: Robert Daniel Nass, et al.
Published: (2021-04-01)

Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus
by: A. Jeppsson, et al.
Published: (2023-07-01)

Evaluation of serum neurofilament light chain and glial fibrillary acidic protein in the diagnosis of Alzheimer’s disease
by: Tangni Fang, et al.
Published: (2024-01-01)

Plasma neurofilament light and its association with all-cause mortality risk among urban middle-aged men and women
by: May A. Beydoun, et al.
Published: (2022-06-01)

Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons
by: Markus T. Sainio, et al.
Published: (2022-02-01)

PNA6, a Lactosyl Analogue of Angiotensin-(1-7), Reverses Pain Induced in Murine Models of Inflammation, Chemotherapy-Induced Peripheral Neuropathy, and Metastatic Bone Disease
by: Maha I. Sulaiman, et al.
Published: (2023-10-01)

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
by: Federico Verde, et al.
Published: (2023-03-01)

Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients
by: Maria Antonella Zingaropoli, et al.
Published: (2022-08-01)

Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple Sclerosis
by: Undine Proschmann, et al.
Published: (2021-04-01)

Sustained Increase in Serum Glial Fibrillary Acidic Protein after First ST-Elevation Myocardial Infarction
by: Jan Traub, et al.
Published: (2022-09-01)

The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01)

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
by: Magnus Gisslén, et al.
Published: (2016-01-01)

Predictive value of serum neurofilament light chain for persistent cognitive deficits in elderly depressive patients
by: Christoph Linnemann, et al.
Published: (2021-04-01)

Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation
by: Lenka Fialova, et al.
Published: (2017-09-01)

Association between neurofilament light chain concentration and lesion size in dogs with meningoencephalitis of unknown origin
by: Taesik Yun, et al.
Published: (2023-07-01)

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
by: Nuole Zhu, et al.
Published: (2021-12-01)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
by: Andre Strydom, et al.
Published: (2018-04-01)